(11-hydroxy-9-oxo-2,3,9,10-tetrahydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-3-yl)methyl benzoate (56615-05-5)

Identification
Name:	(11-hydroxy-9-oxo-2,3,9,10-tetrahydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-3-yl)methyl benzoate
Synonyms:	NSC299218;NSC-299218;56615-05-5
CAS:	56615-05-5
Molecular Formula:	C₁₆H₁₅N₃O₅
Molecular Weight:	329.3074
InChI:	InChI=1/C16H15N3O5/c20-11-6-7-19-14-13(21)12(18-16(19)17-11)10(24-14)8-23-15(22)9-4-2-1-3-5-9/h1-7,10,12-14,21H,8H2,(H,17,18,20)
Molecular Structure:
Properties
Density:	1.63g/cm³
Refractive index:	1.744
Safety Data

Other Product

(8-bromo-11-hydroxy-9-oxo-2,3,9,10-tetrahydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-3-yl)methyl benzoate
11-hydroxy-3-(hydroxymethyl)-2,10-dihydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-9(3H)-one
Propanoic acid, 2-methyl-,8-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-1-yl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ester
Propanoic acid, 2,2-dimethyl-,8-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-1-yl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ester
Carbonic acid,8-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-1-yl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ethyl ester
1H-Pyrrolo[2,1-c][1,4]benzodiazepine-11-sulfinicacid,2-(3-amino-3-oxo-1-propenyl)-5,10,11,11a-tetrahydro-9-hydroxy-8-methyl-5-oxo-,monosodium salt (9CI)
2-Propenamide,3-(11-ethoxy-5,10,11,11a-tetrahydro-9-hydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-N-methyl-(9CI)
2-Propenamide,3-(5,10,11,11a-tetrahydro-9-hydroxy-11-methoxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-
(2E)-3-[(11R,11aS)-9-hydroxy-11-methoxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl]prop-2-enenitrile
(2E)-3-(9-hydroxy-11-methoxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)prop-2-enamide
(+)-N-Methyl-3-(5,10,11,11a-tetrahydro-9-hydroxy-11-methoxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepine-2-yl)propenamide
7H-Pyrazolo[1,2-d][1,4,5]oxadiazepin-7-one,8-[2-(4-chlorophenyl)-5-methyl-4-thiazolyl]-1,2,4,5-tetrahydro-9-hydroxy-
a-Xylopyranose,5-C-[9,10-dihydro-4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9-anthracenyl]-,1-benzoate (9CI)
Carbonic acid,8-[2-(4-chlorophenyl)-5-methyl-4-thiazolyl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ethyl ester
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
5,9-Methanopyrimido[4,5-b]azocin-4(3H)-one,2-amino-5,6,7,8,9,10-hexahydro-9-hydroxy-10-methyl-
Hexadecanoic acid,(2R)-2,5-dihydroxy-11-(7-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-3-yl)-5-oxido-10-oxo-4,6-dioxa-9-aza-5-phosphaundec-1-yl ester
2-Propenamide,N,N-dimethyl-3-[(11R,11aS)-5,10,11,11a-tetrahydro-11-hydroxy-9-methoxy-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl]-,(2E)-
1H-Cyclodeca[c]pyran-9-carboxylic acid,3-(2,5-dihydro-5-hydroxy-2-oxo-3- furanyl)-3,4,4a,5,10,11,12,12a-octahydro-4amethyl- 10-methylene-1-oxo-,methyl ester
1/C7H3Cl3O/c8-5-1-2-6(9)7(10)4(5)3-11/h1-3